This sounds like an apologist's explanation for an inconvenient truth. Sounds reasonable, but falls apart when confronted with actual data. (Edit: I'm sure you

This sounds like an apologist's explanation for an inconvenient truth. Sounds reasonable, but falls apart when confronted with actual data. (Edit: I'm sure you were paraphrasing what you'd read somewhere.) Here's a quote from the Boston Globe's 5/7/2000 article: >> Three years before Prozac received approval by the US Food and Drug Administration in late 1987, the German BGA, that country’s FDA equivalent, had such serious reservations about Prozac’s safety that it refused to approve the antidepressant based on Lilly’s studies showing that previously nonsuicidal patients who took the drug had a fivefold higher rate of suicides and suicide attempts than those on older antidepressants, and a threefold higher rate than those taking placebos. >> Lilly’s own figures, in reports made available to the Globe, indicate that 1 in 100 previously nonsuicidal patients who took the drug in early clinical trials developed a severe form of anxiety and agitation called akathisia, causing them to attempt or commit suicide during the studies. -- http://ahrp.org/prozac-revisited-concerns-about-suicides-surface-boston-globe/ http://ahrp.org/prozac-revisited-concerns-about-suicides-sur... (I don't know anything about this site, but I've read the quote elsewhere so I'm sure it's a true copy of what the Globe actually printed).